ICON PLC
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
55 / 240
Position in country
79 / 187
Return on Assets, %
3.5
-2.7
Net income margin, %
10.4
-6.7
EBITDA margin, %
20.5
5.6
Debt to Equity, %
40.8
15.1
Intangible assets and goodwill, %
75.7
4.7
Revenue CAGR 3Y, %
42.6
12.8
Total Equity change 1Y, %
8.7
-2.4
Revenue Y, % chg
4.8
0
P/E
41.3
32.1
P/BV
2.7
2
P/S
3.1
4.1
EV/S
3.5
3.6
EV/EBITDA
17.5
7.8
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
16
48.9
Forward P/E
19.7
25.5
Expected dividend per share
0
0
Payout Ratio, %
0
10.1
Competitors
Ranks
-
Lonza Group AG
00%
-
Samsung Biologics Co Ltd
00%
-
ICON PLC
00%
-
IQVIA Holdings Inc
00%
-
West Pharmaceutical Services Inc
00%
-
Agilent Technologies Inc
00%
-
Thermo Fisher Scientific Inc
00%
-
Danaher Corp
00%
-
Mettler-Toledo International Inc
00%
-
Sartorius Stedim Biotech SA
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Ireland; Republic of
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Sub-sector
Health Care
Capitalization (millions of $)
25243.4
Ticker
ICLR.O
ISIN
IE0005711209
IPO date
1998-05-15
Availability on Russian exchanges
Yes
Reporting for
2024-02-23
Date fact. publication of reports
2023-12-31
Company Description
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: